“I am very annoyed”: Pharma execs blast RFK Jr.’s attack on vaccines
Ars Technica • • general
Key Points:
- Pharmaceutical executives, including Pfizer CEO Albert Bourla, have expressed strong frustration and disappointment with Health Secretary Robert F. Kennedy Jr.'s anti-vaccine agenda, calling it politically motivated and lacking scientific merit.
- Kennedy's recent drastic reduction of the childhood vaccine schedule from 17 to 11 vaccines bypassed standard scientific review processes, making the US an outlier compared to peer countries that recommend more vaccinations.
- Leading medical organizations, such as the American Academy of Pediatrics, are preparing legal challenges to block these changes amid concerns over public health impacts.
- Executives from Moderna, Merck, and Sanofi warned that anti-vaccine rhetoric threatens not only childhood and mRNA vaccines but also seasonal flu vaccination rates, with some suggesting the industry
